Google
 
Web www.vitaminlore.com
www.eniva.com

Atenolol

Also indexed as: Tenormin®

Combination drugs: AtenixCo®, Beta-Adalat®, Co-Tendione, Kalten®, Tenben®, Tenchlor®, Tenif®, Tenoret 50®, Tenoretic®, Totaretic®

Atenolol is a beta-blocker drug used to treat some heart conditions, reduce the symptoms of angina pectoris (chest pain), lower blood pressure in people with hypertension, and treat people after heart attacks.

Interactions with Dietary Supplements

Potassium
Some beta-adrenergic blockers (called “nonselective” beta blockers) decrease the uptake of potassium from the blood into the cells,1 leading to excess potassium in the blood, a potentially dangerous condition known as hyperkalemia.2 People taking beta-blockers should therefore avoid taking potassium supplements, or eating large quantities of fruit (e.g., bananas), unless directed to do so by their doctor.

Interactions with Herbs

Pleurisy root
As pleurisy root and other plants in the Aesclepius species contain cardiac glycosides, it is best to avoid use of pleurisy root with heart medications such as atenolol.3

Interactions with Foods and Other Compounds

Food
Atenolol may be taken with or without food.4

Alcohol
Atenolol may cause drowsiness, dizziness, lightheadedness, or blurred vision.5 Alcohol may intensify these effects and increase the risk of accidental injury. To prevent problems, people taking atenolol should avoid alcohol.

Tobacco
In a double-blind study of ten cigarette smokers with angina treated with atenolol for one week, angina episodes were significantly reduced during the nonsmoking phase compared to the smoking phase.6 People with angina taking atenolol who do not smoke should avoid starting. Those who smoke should consult with their prescribing doctor about quitting.

Summary of Interactions for Atenolol

Depletion or interference None known
Adverse interaction High-potassium foods*
Pleurisy root*
Potassium supplements*
Tobacco
Side effect reduction/prevention None known
Supportive interaction None known
Reduced drug absorption/bioavailability None known

For the convenience of the reader, the information in the summary is categorized as follows: “Depletion or interference” indicates the drug may deplete or interfere with the absorption or function of the supplement or herb. “Adverse interaction” indicates that the supplement or herb used together with the drug may result in undesirable effects. “Side effect reduction/prevention” indicates the supplement or herb may reduce the likelihood and/or severity of a potential side effect caused by the drug. “Supportive interaction” indicates the supplement or herb may support or aid the function of the drug. “Reduced drug absorption/bioavailability” indicates that the supplement or herb may decrease the absorption and/or activity of the drug in the body. An asterisk (*) next to an item in the summary indicates that the interaction is supported only by weak, fragmentary, and/or contradictory scientific evidence.

References:

1. Rosa RM, Silva P, Young JB, et al. Adrenergic modulation of extrarenal potassium disposal. N Engl J Med 1980;302:431–4.

2. Lundborg P. The effect of adrenergic blockade on potassium concentrations in different conditions. Acta Med Scand Suppl 1983;672:121–6 [review].

3. Newall CA, Anderson LA, Phillipson JD. Herbal Medicines: A Guide for Health-Care Professionals. London: Pharmaceutical Press, 1996, 213–4.

4. Threlkeld DS, ed. Diuretics and Cardiovasculars, Beta-Adrenergic Blocking Agents. In Facts and Comparisons Drug Information. St. Louis, MO: Facts and Comparisons, Feb 1993, 158L.

5. Threlkeld DS, ed. Diuretics and Cardiovasculars, Beta-Adrenergic Blocking Agents. In Facts and Comparisons Drug Information. St. Louis, MO: Facts and Comparisons, Feb 1993, 158L.

6. Deanfield J, Wright C, Krikler S, et al. Cigarette smoking and the treatment of angina with propranolol, atenolol, and nifedipine. N Engl J Med 1984;310:951–4.